| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 10/02/2001 | US6297358 RsbV-1 from staphylococcus aureus |
| 10/02/2001 | US6297221 Method for promoting angiogenesis with a nucleic acid construct comprising an SM22α0 promoter |
| 10/02/2001 | US6297220 Recombinant adenovirus comprising a dna sequence that codes for a gene product is delivered to a cardiac or vascular smooth muscle cell and the cell is maintained until that gene product is expressed. |
| 10/02/2001 | US6297219 Site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 10/02/2001 | US6297050 Activation of t-cell response; mix peptides with sample containing t-cells and detect bound human leukocyte antigens |
| 10/02/2001 | US6297039 Amps from Streptococcus pneumoniae |
| 10/02/2001 | US6297036 YAK-1 related serine/threonine protein kinase-HTLAR33 |
| 10/02/2001 | US6297029 Mammalian artificial chromosomes |
| 10/02/2001 | US6297028 IL-2R-associated polypeptide and DNA molecules coding therefor |
| 10/02/2001 | US6297026 Nucleic acids encoding the C140 receptor |
| 10/02/2001 | US6297011 Mammalian tolloid-like gene and protein |
| 10/02/2001 | US6297004 Retroviral particles that infect eukaryotic cells; for somatic gene therapy; for use as diagnostic tool in viral detection; viricides |
| 10/02/2001 | US6297003 Methods for the detection of a novel hepatitis C virus (HCV) terminal 3′ noncoding region |
| 10/02/2001 | US6296851 For screening antibiotics |
| 10/02/2001 | US6296846 Induced tolerance to xenografts |
| 10/02/2001 | US6296845 Contacting under infective conditions, a recombinant replication deficient adenovirus lacking an expressed viral oncoprotein capable of binding functional p53 tumor suppressor gene product, with neoplastic cellsnon-neoplastic cells |
| 10/02/2001 | CA2159626C Method for delivering beneficial compositions to hair follicles |
| 09/30/2001 | CA2340461A1 Hirulog-like peptide and gene therapy |
| 09/27/2001 | WO2001071029A1 Diagnosis of a person's risk of developing alcoholism |
| 09/27/2001 | WO2001071017A2 Modified nodavirus rna for gene delivery |
| 09/27/2001 | WO2001071015A2 Non-squamous epithelium-specific transcription |
| 09/27/2001 | WO2001071007A2 GENETIC POLYMORPHISM OF MxA PROTEIN AND USE THEREOF |
| 09/27/2001 | WO2001071005A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 09/27/2001 | WO2001070992A1 Proteins and polypeptides from haemophilus influenza involved in paracytosis, nucleotide sequences encoding them and uses thereof |
| 09/27/2001 | WO2001070989A2 Genetically modified plants and plant cells comprising heterologous heavy metal transport and complexation proteins |
| 09/27/2001 | WO2001070982A2 Brca-1 regulators and methods of use |
| 09/27/2001 | WO2001070979A2 Genes, compositions, kits, and method for identification, assessment, prevention and therapy of ovarian cancer |
| 09/27/2001 | WO2001070978A2 Polypeptides and nucleic acids encoding same |
| 09/27/2001 | WO2001070974A1 Novel protein, process for producing the same and use thereof |
| 09/27/2001 | WO2001070971A2 Regulation of human mas oncogene-related g protein-coupled receptor |
| 09/27/2001 | WO2001070969A2 Regulation of human latrophilin-like g protein-coupled receptor |
| 09/27/2001 | WO2001070968A2 Production of recombinant blood clotting factors in human cell lines |
| 09/27/2001 | WO2001070955A2 Identification of essential genes in prokaryotes |
| 09/27/2001 | WO2001070953A2 Identification of modulators of the inteferon gamma signaling pathway and their use in restenosis treatment |
| 09/27/2001 | WO2001070952A1 Human gata-5 transcription factor |
| 09/27/2001 | WO2001070951A2 Agent for the diagnosis and therapy of viral diseases |
| 09/27/2001 | WO2001070950A2 Antisense nucleic acid molecules targeted to type i collagenase (mmp-1) for inhibition of melanoma invasion |
| 09/27/2001 | WO2001070941A2 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis |
| 09/27/2001 | WO2001070940A1 Genetic constructs for regulated expression of insulin |
| 09/27/2001 | WO2001070816A2 Ecdysone receptor-based inducible gene expression system |
| 09/27/2001 | WO2001070814A2 Regulation of human rta-like g protein-coupled receptor |
| 09/27/2001 | WO2001070810A2 Atp binding cassette transporter 1 (abc1) gene polymorphisms and uses thereof for the diagnosis and treatment of lipid disorders, cardiovascular diseases and inflammatory diseases |
| 09/27/2001 | WO2001070808A2 Angiogenesis - associated proteins, and nucleic acids encoding the same |
| 09/27/2001 | WO2001070804A1 7 human ovarian and ovarian cancer associated proteins |
| 09/27/2001 | WO2001070798A2 Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent |
| 09/27/2001 | WO2001070776A2 Nimr compositions and their methods of use |
| 09/27/2001 | WO2001070775A2 Wnt-1 related polypeptides, and nucleic acids encoding the same |
| 09/27/2001 | WO2001070771A2 Acute neuronal induced calcium binding protein type 1 ligand |
| 09/27/2001 | WO2001070767A2 Therapeutic anti-melanoma compounds |
| 09/27/2001 | WO2001070763A1 Modified blood clotting factors and methods of use |
| 09/27/2001 | WO2001070276A2 Aav5 vector for transducing brain cells and lung cells |
| 09/27/2001 | WO2001070254A1 Use of human not1 and not1a orphan receptors |
| 09/27/2001 | WO2001070247A2 Salmonella vaccine materials and methods |
| 09/27/2001 | WO2001070244A1 Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses |
| 09/27/2001 | WO2001070175A2 Osteocalcin promoter directed adenovirus replicaton for therapy |
| 09/27/2001 | WO2001021802B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 09/27/2001 | WO2001020013A3 Viral replicons and viruses dependent on inducing agents |
| 09/27/2001 | WO2001018546A3 Screening for inhibitors of 'paired helical filaments' |
| 09/27/2001 | WO2001018056A3 Method of gene therapy for improving the efficiency of cancer therapy |
| 09/27/2001 | WO2001017547A3 Bmp-9 compositions and methods for inducing differentiation of cholinergic neurons |
| 09/27/2001 | WO2001016170A3 Card proteins involved in cell death regulation |
| 09/27/2001 | WO2000057837A8 Compositions and methods for effecting the levels of cholesterol |
| 09/27/2001 | WO2000046386A9 Gene repair involving the induction of double-stranded dna cleavage at a chromosomal target site |
| 09/27/2001 | US20010025099 G protein-coupled receptor polypeptides and polyncleotides |
| 09/27/2001 | US20010025030 cDNA for human methylenetetrahydrofolate reductase and uses thereof |
| 09/27/2001 | US20010024827 Which express a neuron-specific marker and which can give rise to progeny which can differentiate into neuronal cells; for treatment of neuronal disorders |
| 09/27/2001 | US20010024824 Stem cells and their use in transplantation |
| 09/27/2001 | US20010024817 Viral nucleotide sequences |
| 09/27/2001 | US20010024807 Polynucleotides encoding crippled selectable marker such as neomycin resistance; heterologous polypeptides of interest; amplifiable selectable marker such as dehydrofolate reductase |
| 09/27/2001 | US20010024792 Method of detecting risk of type II diabetes based on mutations found in carboxypeptidase E |
| 09/27/2001 | US20010024783 By administering a heat and RnaseH resistant antisense agent and detecting the presence in a body fluid sample of a nuclease-resistant heteroduplex of the antisense oligomer and the target RNA; detecting infective agents, pregnancy |
| 09/27/2001 | DE10015413A1 Composition for treating and diagnosing viral infections, caused by adenovirus, comprises an agent that modifies function of YB-1 protein, and YB-1 specific antibodies |
| 09/27/2001 | CA2406993A1 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 09/27/2001 | CA2404260A1 Identification of essential genes in prokaryotes |
| 09/27/2001 | CA2404253A1 Novel ecdysone receptor-based inducible gene expression system |
| 09/27/2001 | CA2404216A1 Novel polypeptides, and nucleic acids encoding the same |
| 09/27/2001 | CA2403815A1 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis |
| 09/27/2001 | CA2403809A1 Angiogenesis - associated proteins, and nucleic acids encoding the same |
| 09/27/2001 | CA2403795A1 Osteocalcin promoter directed adenovirus replicaton for therapy |
| 09/27/2001 | CA2403684A1 Therapeutic anti-melanoma compounds |
| 09/27/2001 | CA2403444A1 Restenosis treatment |
| 09/27/2001 | CA2403436A1 Acute neuronal induced calcium binding protein type 1 ligand |
| 09/27/2001 | CA2403434A1 Human gata-5 transcription factor |
| 09/27/2001 | CA2402834A1 Brca-1 regulators and methods of use |
| 09/27/2001 | CA2402816A1 Antisense nucleic acid molecules targeted to type i collagenase (mmp-1) for inhibition of melanoma invasion |
| 09/27/2001 | CA2402285A1 Nimr compositions and their methods of use |
| 09/27/2001 | CA2402252A1 Salmonella vaccine materials and methods |
| 09/27/2001 | CA2401887A1 Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent |
| 09/27/2001 | CA2400638A1 7 human ovarian and ovarian cancer associated proteins |
| 09/27/2001 | CA2383848A1 Diagnosis of a person's risk of developing alcoholism |
| 09/27/2001 | CA2374073A1 Novel polypeptides and nucleic acids encoding same |
| 09/26/2001 | EP1136571A2 Detection of polymorphisms in the MxA gene to predict the response of an hepatitis C virus infected individual to interferon therapy |
| 09/26/2001 | EP1136561A2 Targeting gene therapy |
| 09/26/2001 | EP1136558A1 Genetically modified plants and plant cells comprising heterologous heavy metal transport and complexation proteins |
| 09/26/2001 | EP1136557A1 Proteins and polypeptides from Haemophilus influenzae involved in paracytosis, nucleotide sequences encoding them and uses thereof |
| 09/26/2001 | EP1136554A1 ATP binding cassette transporter 1 (ABC1) gene polymorphisms and uses thereof for the diagnosis and treatment of lipid disorders, cardiovascular diseases and inflammatory diseases |
| 09/26/2001 | EP1136552A1 ATP binding cassette transporter 1 (ABC1) gene polymorphisms and uses thereof for the diagnosis and treatment of lipid disorders, cardiovascular diseases and inflammatory diseases |
| 09/26/2001 | EP1136547A2 Adamts polypeptides, nucleic acids encoding them, and uses thereof |
| 09/26/2001 | EP1136083A1 Gene therapy for cardiomyopathy |
| 09/26/2001 | EP1135688A2 Methods and compositions useful for targeting activated vitronectin receptor alpha(nu)-beta(3) |